Skip to main content
Clinical Trials/NCT00885456
NCT00885456
Completed
Phase 2

Effectiveness of a Program of Rehabilitative Exercise and Education to Avert Vascular Events After Non-disabling Stroke: A Multi-site RCT

Marilyn MacKay-Lyons2 sites in 1 country187 target enrollmentOctober 30, 2011

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Transient Ischemic Attack
Sponsor
Marilyn MacKay-Lyons
Enrollment
187
Locations
2
Primary Endpoint
diastolic blood pressure
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

The objective of the Program of Rehabilitative Exercise and Education to avert Vascular Events after Non-disabling stroke and Transient ischemic attack (PREVENT) Trial is to determine whether the timely delivery of secondary stroke prevention strategies will reduce modifiable vascular risk factors in two groups of people who have survived NDS or TIA. One group will receive a comprehensive education and exercise program (PREVENT); the other group will receive usual care (USUAL CARE). We will measure modifiable vascular risk factors in both groups. We will also compare the effects of PREVENT vs USUAL CARE on exercise capacity, walking endurance, and daily physical activity. In addition, we will compare thinking ability, depression, achievement of personal goals for healthy behavior, and health-related goal attainment and health-related quality of life. Finally, we will compare outcomes in urban and rural settings as well as costs of the PREVENT program and USUAL CARE in order to assess sustainability of the PREVENT program.

Registry
clinicaltrials.gov
Start Date
October 30, 2011
End Date
June 30, 2017
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Marilyn MacKay-Lyons
Responsible Party
Sponsor Investigator
Principal Investigator

Marilyn MacKay-Lyons

Affiliated Scientist

Nova Scotia Health Authority

Eligibility Criteria

Inclusion Criteria

  • Males and females
  • Over 17 years of age.
  • Diagnosis of first probable or definite TIA or non-disabling stroke (National Institutes of Health Stroke Scale \< 6)
  • Post-event interval of \<90 days.
  • Residence within 75 km of intervention site.
  • Orientation to time, place and person and ability to follow simple 3-step commands.
  • Ability and willingness to provide informed consent.

Exclusion Criteria

  • Evidence of intracranial hemorrhage on MRI or CT scan.
  • Presence of contraindications to exercise testing and training, in accordance with American College of Sports Medicine Guidelines.
  • Participation in another study that could potentially confound the outcomes of this trial.

Outcomes

Primary Outcomes

diastolic blood pressure

Time Frame: baseline, post-intervention, 6 months, 12 months

systolic blood pressure (primary vascular risk factor being assessed)

Time Frame: baseline, post-intervention, 6 months, 12 months

waist circumference

Time Frame: baseline, post-intervention, 6 months, 12 months

12-hour fasting glucose/hemoglobin A1C

Time Frame: baseline, post-intervention, 6 months, 12 months

12-hour fasting lipid profile

Time Frame: baseline, post-intervention, 6 months, 12 months

Secondary Outcomes

  • walking endurance(baseline, post-intervention, 6 months, 12 months)
  • cigarette smoking(baseline, post-intervention, 6 months, 12 months)
  • exercise capacity(baseline, post-intervention, 12 months)
  • daily physical activity(baseline, post-intervention, 6 months, 12 months)
  • cognition(baseline, 12 months)
  • depression(baseline, post-intervention, 6 months, 12 months)
  • health-related quality of life(baseline, post-intervention, 6 months, 12 months)
  • health-related goal attainment(baseline, post-intervention, 6 months, 12 months)
  • direct health costs(baseline, post-intervention, 6 months, 12 months)
  • secondary vascular events(baseline, post-intervention, 6 months, 12 months)
  • medication adherence(baseline, post-intervention, 6 months, 12 months)
  • daily step count(baseline, post-intervention, 12 months)

Study Sites (2)

Loading locations...

Similar Trials